129 related articles for article (PubMed ID: 17198086)
1. A novel approach to generate host antitumor T cells: adoptive immunotherapy by T cells maturing in xenogeneic thymus.
Zhao Y; Sun Y; Niu Z; Li Q; Peng J; Wang J; Langnas AN
J Immunother; 2007 Jan; 30(1):83-8. PubMed ID: 17198086
[TBL] [Abstract][Full Text] [Related]
2. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.
Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M
Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242
[TBL] [Abstract][Full Text] [Related]
3. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
[TBL] [Abstract][Full Text] [Related]
4. Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma.
Kline J; Brown IE; Zha YY; Blank C; Strickler J; Wouters H; Zhang L; Gajewski TF
Clin Cancer Res; 2008 May; 14(10):3156-67. PubMed ID: 18483384
[TBL] [Abstract][Full Text] [Related]
5. Achievement of cellular immunity and discordant xenogeneic tolerance in mice by porcine thymus grafts.
Zhao Y; Sun Z; Sun Y; Langnas AN
Cell Mol Immunol; 2004 Jun; 1(3):173-9. PubMed ID: 16219164
[TBL] [Abstract][Full Text] [Related]
6. Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
Jorritsma A; Bins AD; Schumacher TN; Haanen JB
Cancer Res; 2008 Apr; 68(7):2455-62. PubMed ID: 18381454
[TBL] [Abstract][Full Text] [Related]
7. The critical role of mouse CD4+ cells in the rejection of highly disparate xenogeneic pig thymus grafts.
Zhao Y; Swenson K; Wekerle T; Rodriguez-Barbosa JI; Arn JS; Sykes M
Xenotransplantation; 2000 May; 7(2):129-37. PubMed ID: 10961297
[TBL] [Abstract][Full Text] [Related]
8. Autolymphocyte therapy. II. Dependence of in vivo anti-tumor specificity and long-term immunity against murine melanoma and carcinoma on ex vivo activated donor memory T-cells.
Gold JE; Osband ME
Clin Immunol Immunopathol; 1994 Jun; 71(3):325-32. PubMed ID: 7911078
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
Watanabe MA; Almeida DO; Serrano SV; Sales VS; Soares FA; de Lucca FL
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):393-8. PubMed ID: 9193794
[TBL] [Abstract][Full Text] [Related]
10. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.
Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y
Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256
[TBL] [Abstract][Full Text] [Related]
11. Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
Hu K; Xiong J; Ji K; Sun H; Wang J; Liu H
Immunol Lett; 2007 Oct; 113(1):19-28. PubMed ID: 17868906
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic murine B16 cell-pulsed dendritic cells induce effective protection against melanoma in mice.
Joseph-Pietras D; Carlier A; Madoulet C; Albert P
Anticancer Res; 2007; 27(6B):3865-74. PubMed ID: 18225544
[TBL] [Abstract][Full Text] [Related]
13. Immune restoration by fetal pig thymus grafts in T cell-depleted, thymectomized mice.
Zhao Y; Fishman JA; Sergio JJ; Oliveros JL; Pearson DA; Szot GL; Wilkinson RA; Arn JS; Sachs DH; Sykes M
J Immunol; 1997 Feb; 158(4):1641-9. PubMed ID: 9029100
[TBL] [Abstract][Full Text] [Related]
14. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.
Thanarajasingam U; Sanz L; Diaz R; Qiao J; Sanchez-Perez L; Kottke T; Thompson J; Chester J; Vile RG
Cancer Res; 2007 Jan; 67(1):300-8. PubMed ID: 17210711
[TBL] [Abstract][Full Text] [Related]
15. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells.
Li J; Theofanous L; Stickel S; Bouton-Verville H; Burgin KE; Jakubchak S; Wagner TE; Wei Y
Int J Oncol; 2007 Jul; 31(1):193-7. PubMed ID: 17549421
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor effect of splenocytes treated with RNA from animals immunized with bovine myelin basic protein.
Watanabe MA; De Lucca FL
Cell Mol Biol (Noisy-le-grand); 1996 Mar; 42(2):249-54. PubMed ID: 8696262
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes.
Rossi GR; Mautino MR; Unfer RC; Seregina TM; Vahanian N; Link CJ
Cancer Res; 2005 Nov; 65(22):10555-61. PubMed ID: 16288048
[TBL] [Abstract][Full Text] [Related]
18. Highly disparate xenogeneic skin graft tolerance induction by fetal pig thymus in thymectomized mice: Conditioning requirements and the role of coimplantation of fetal pig liver.
Zhao Y; Rodriguez-Barbosa JI; Swenson K; Zhao G; Arn JS; Sykes M
Transplantation; 2001 Nov; 72(10):1608-15. PubMed ID: 11726819
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice.
Hardy B; Yampolski I; Kovjazin R; Galli M; Novogrodsky A
Cancer Res; 1994 Nov; 54(22):5793-6. PubMed ID: 7954401
[TBL] [Abstract][Full Text] [Related]
20. Administration of DTC gives evidence of a role of the thymus in the control and regulation of factors inducing thymocyte differentiation in the mouse.
Renoux G; Renoux M
Thymus; 1980 Dec; 2(3):139-46. PubMed ID: 6258272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
